Date published: 2025-10-10

00800 4573 8000

SCBT Portrait Logo
Seach Input

ADAMTS Aktivatoren

A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent extracellular enzymes that play a crucial role in a myriad of biological processes. These enzymes are active participants in the cleavage, restructuring, and maintenance of the extracellular matrix (ECM), which is a vital component of tissues and organs. Members of the ADAMTS family are involved in the proteolytic processing of various substrates within the ECM. Its signaling mechanisms are embedded within a web of regulatory pathways that include cytokine networks, growth factors, and other enzymes. These pathways modulate ADAMTS expression levels and enzymatic activity, implicating it in ECM remodeling, cell migration, and the modulation of other cellular behaviors. Factors like epigenetic regulation, substrate availability, and endogenous further add layers of complexity to the regulation of ADAMTS activity.

ADAMTS activators are aimed at understanding molecules that can specifically or indirectly modulate the activity of ADAMTS family members. While several types of molecules are being investigated for their role in activating or facilitating ADAMTS function, these range from small organic compounds to larger biological molecules. Small molecules like HDAC and TGF-β have been researched for their impact on the epigenetic and transcriptional regulation of ADAMTS family members, respectively. Others like MMP can indirectly contribute by preserving the availability of substrates in the ECM for ADAMTS proteins. Activators may also interact with ADAMTS members through various mechanisms such as inhibition of opposing pathways or through complex signaling cascades.

Siehe auch...

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

HDAC-Inhibitoren könnten die epigenetische Regulierung der ADAMTS-20-Genexpression beeinflussen.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Durch die Hemmung von TGF-β könnten diese möglicherweise die ADAMTS-20-Expression hochregulieren, wenn TGF-β ein Suppressor ist.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA-Methyltransferase-Inhibitoren könnten den Methylierungsstatus des ADAMTS-20-Gens beeinflussen und dessen Expression möglicherweise verstärken.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$33.00
$73.00
$265.00
$112.00
34
(1)

Kann ADAMTS-20 aktivieren, indem es oxidative Stressbedingungen reduziert, die es sonst hemmen.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

NF-κB-Inhibitoren könnten ADAMTS-20 möglicherweise durch Unterdrückung der NF-κB-Signalübertragung hochregulieren, wenn NF-κB als Suppressor wirkt.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Wnt-Pathway-Inhibitoren könnten ADAMTS-20 durch Beeinflussung der Wnt-Signalübertragung beeinflussen, die bekanntermaßen an der Umgestaltung der ECM beteiligt ist.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

PKC-Inhibitoren könnten verschiedene Signalwege beeinflussen, die ADAMTS-20 indirekt aktivieren können.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK/STAT-Inhibitoren können die Zytokin-Signalübertragung beeinflussen, die die ADAMTS-20-Expression oder -Aktivität beeinflusst.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

MEK-Inhibitoren könnten MAPK-Wege beeinflussen, die ADAMTS-20 beeinflussen.

Cobalt(II) chloride

7646-79-9sc-252623
sc-252623A
5 g
100 g
$63.00
$173.00
7
(1)

HIF-1α-Stabilisatoren könnten möglicherweise die hypoxiebedingte Aktivierung oder Expression von ADAMTS-20 beeinflussen.